Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Unknown

Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer

3D-printed Template for Iodine-125 Seed Implantation Therapy in Patients With Locally Advanced Pancreatic Cancer: a Multicenter Study

Outcome
Outcome unknown
Phase
No phase (not a drug trial)
Status
Unknown
Study type
Interventional
Start
28 March 2019
Listed end
30 September 2021
Enrollment
220 participants
Sites
8
Primary outcomes
Objective Response Rate (ORR)
Sponsor type
Academic / other
Results posted
No
Last update
6 February 2020

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study evaluates the application of 3D-printed template for iodine-125 seed implantation therapy in patients with locally advanced pancreatic cancer. Half of participants will receive 3D-printed coplanar template, while the other half will receive 3D-printed non-coplanar template.

Detailed description public domain (ClinicalTrials.gov)

Dosimetric verification was performed after implantation. Pre- and postoperative D90, V100, and V150 were calculated. The success rate of iodine-125 seed implantation, dosimetric parameters, objective response rate (ORR),overall survival (OS),toxicities and quality of life of two treatment regimens and complications were analyzed and compared between the two groups.